Page 11 - அமெரிக்கன் கல்லூரி ஆஃப் இருதயவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Amarin (AMRN) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Clene Nanomedicine Appoints Dr Vallerie McLaughlin to its
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Stealth BioTherapeutics Reports Second Quarter 2021 Financial Results And Recent Business Highlights
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
MedCity News
Software to calculate the right dose of medicine for heart failure patients gets breakthrough device designation
Biofourmis, a Boston-based digital health startup, recently received breakthrough designation for its digital therapeutic to help ensure heart failure patients receive medications that are consistent with clinical evidence at the right dose.
Shares0
A healthcare provider logs into Biofourmis’ platform. The company received a breakthrough device designation for its software to help physicians prescribe the right dose of medication to patients with heart failure.
The Food and Drug Administration granted breakthrough device designation to a startup building software to help physicians prescribe the right dose of medication to patients with heart failure. Boston-based Biofourmis pulls in patients’ lab data, symptoms and vitals to recommend specific medications at a specific dose to their doctor.